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Synthetic biology is an interdisciplinary field that takes top-down approaches to understand and engineer biological systems 
through design-build-test cycles. A number of advances in this relatively young field have greatly accelerated such engineering 
cycles. Specifically, various innovative tools were developed for in silico biosystems design, DNA de novo synthesis and as-
sembly, construct verification, as well as metabolite analysis, which have laid a solid foundation for building biological found-
ries for rapid prototyping of improved or novel biosystems. This review summarizes the state-of-the-art technologies for syn-
thetic biology and discusses the challenges to establish such biological foundries.  
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Synthetic biology is an extension of the long pursuit of abil-
ity to forward-engineer biological systems. Enabled by mo-
lecular and systems biology tools, synthetic biology 
emerged in the 1990s [1]. Thanks to advances in robust 
DNA assembly methods [2] and standardized genetic parts 
[3,4], this interdisciplinary field has undergone exponential 
growth in the first decade of the 21st century and demon-
strated its tremendous potential in understanding and engi-
neering biosystems. As a bottom-up observation oriented 
science, biology needs new dimensions to explore increas-
ingly complicated systems of interest. As American physi-
cist Richard Feynman stated, “What I cannot create, I do not 
understand”, the capability of de novo designing and build-
ing genetic devices and systems empowers a top-down ap-
proach to study life sciences. For example, by constructing 
simplified genetic circuits, stochastic gene expression can 
be modeled, which uncovers mechanisms of phenotypical 
variations in isogenic population [5,6]. Cryptic metabolic 
pathways predicted by bioinformatics can be activated by 
refactoring the gene expression machinery to discover novel 
biochemical reactions and products [7,8]. In addition, traits 
can be traced to their genetic background with genome scale 
perturbations [9,10].  
By definition, synthetic biology has great potential in 
revolutionizing the way biosystems are engineered. In met-
abolic engineering, one of the most widely recognized suc-
cesses is the engineered biosynthesis of anti-malarial drug 
artemisinin, the active component of Chinese traditional 
herbal medicine Artemisia annua [11]. Biosynthetic path-
ways were not only optimized for productivity but also con-
trolled by genetic circuits to adapt to a changing environ-
ment [12]. A quorum sensing circuit was employed to pro-
gram environmentally controlled cell invasion for potential 
anti-cancer applications [13]. Dynamic control was intro-
duced in a biodiesel producing pathway to stabilize the level 
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of key intermediates [14]. On a genome scale, tools such as 
oligo-mediated allelic replacement [15] and CRISPR-Cas 
(clustered, regularly interspaced short palindromic re-
peats-CRISPR-associated proteins) system [16,17] are ex-
ploited to perform efficient multiplex genome editing. The-
se tools developed in the past decade have laid the ground 
for synthetic biology. Nevertheless, due to the complexity 
of the biosystems and low success rate, a trial-and-error 
approach is required to survey many variations or combina-
tions when prototyping biosystems. Therefore, it is highly 
desirable to develop high-throughput prototyping capabili-
ties for synthetic biology. 
In the early 2000s, successes in the construction of ge-
netic toggle switches [18], oscillators [19], logic gates [20], 
and so on have initiated the first tide of synthetic biology. 
These early findings implied an analogy between the syn-
thetic biology field and the electronics industry. Soon after, 
like in the electronic industry, efforts have been made to 
standardize and characterize genetic parts that can be 
mixed-and-matched to form progressively complex circuits, 
although most of them still need “hand tuning” to be func-
tional. In early years, wiring electronic circuits was also an 
artisanal job until planar process was developed that al-
lowed consistent fabrication of integrated circuits on a sili-
con wafer [21]. This game-changing technology streamlined 
the manufacturing process and accelerated the industry to 
the astonishing Moore’s law. If the analogy holds, stream-
lining biofabrication process will change the landscape of 
synthetic biology. In the ideal situation, researchers’ ideas 
are transformed to designs in silico, then submitted to au-
tomated prototyping systems and eventually tested in dif-
ferent organisms. With the rapid progress in this arena, we 
see establishing “biological foundries” no longer a fiction. 
This perspective reviews the state-of-the-art technologies 
and discusses the opportunities as well as challenges in 
three major key aspects of biofabrication including design, 
build, and test (Figure 1).  
1  Design 
A typical synthetic biology work flow starts from target 
functionalities such as compounds to be produced, sub-
strates to be assimilated, and regulatory networks to be es-
tablished. Based on prior knowledge, metabolic pathways or 
genetic circuits are designed while parts are selected. Usu-
ally multiple part sets are proposed due to the relatively low 
success rate. Then the DNA constructs are designed for ap-
propriate assembly methods. As an example, Kim and 
co-workers [22] improved a xylose assimilation pathway in 
Saccharomyces cerevisiae by screening a combinatorial 
library. The design began with a 3-gene pathway in 
Scheffersomyces stipitis that converted xylose to xylu-
lose-5-phosphate. Around 20 orthologs of each gene were 














Figure 1 (color online)  Illustration of automated design-build-test cycle 
for the next-generation synthetic biology: Biosystems are designed by 
CAD tools, built by robotic systems, and then tested by high throughput 
analytical instruments. A layout for Illinois Biological Foundry for Ad-
vanced Biomanufacturing (iBioFAB), the automated biofabrication plat-
form at the University of Illinois, USA is highlighted. 
general plasmid map was designed with one set of genes as 
well as yeast endogenous promoters and terminators. Primer 
sequences with overhangs were planned to PCR amplify all 
the orthologs and assemble them combinatorially with the 
DNA assembler method [23]. Such workflow consists of 
two major steps, including (a) design of parts and systems 
and (b) design of the corresponding DNA constructs.  
1.1  Design of parts and systems 
Researchers’ knowledge and experience played an im-
portant role in traditional biosystems design when most of 
the work was done by hand. However, the sizes of databases 
for parts, circuits, and pathways today have expanded far 
beyond any individual’s knowledge. Even if searching for 
each individual part is manageable, searching for combina-
tions of parts will end up in numerous possibilities. The 
tedious manual design process limits research in increas-
ingly complex biosystems. As in the electronic industry, 
computer aided design (CAD) will be the ultimate solution 
which allows optimization and higher throughput in biosys-
tems design. On the part level, Salis and co-workers [24] 
have developed a thermodynamic model to predict the pro-
tein expression level based on the ribosome binding site 
(RBS) sequences in Escherichia coli. A tool was made 
available to design RBSs with varying strengths, which 
greatly helped fine-tuning of genetic circuits and metabolic 
pathways. In S. cerevisiae, synthetic promoters were de-
signed based on the correlation between expression level 
and predicted nucleosome affinity [25]. CAD has broad 
applications in modeling and evaluating gene circuits. 
Graphical user interfaces (GUIs) were also developed to 
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help users pick parts and simulate their designs. A number 
of computational tools were summarized in previous re-
views [26,27]. Growing genomic and metabolomics data 
provide us mechanistic insights on microbial metabolic 
networks. Constraint-based reconstruction and analysis 
(COBRA) was developed to model intracellular metabolism 
[28]. These tools can be used to predict metabolic engi-
neering targets for desired phenotypes. In return, high- 
throughput genome editing and analysis with the newly de-
veloped genome editing tools can potentially provide feed-
back data to further train the metabolic models for more 
precise predictions. Biosynthetic targets sometimes involve 
de novo composition of pathways. A few tools [29] were 
developed to explore the reaction and enzyme databases 
[3032] for discovery of novel biochemical routes. Hatzi-
manikatis and co-workers [33] have developed Biochemical 
Network Integrated Computational Explorer (BNICE) 
which employed enzymatic reaction rules and thermody-
namic properties to search for reactions linking the desired 
substrates and products in silico. BNICE was used to predict 
more than one billion polyketide structures by exploring 
theoretical diversities in the synthetic pathways [34]. Simi-
larly, Hou and co-workers [35] at the University of Minne-
sota have developed Pathway Prediction System (PPS) to 
predict bio-degradation pathways.  
1.2  Design of DNA constructs 
Once the conceptual design of the biosystems is completed, 
the selected parts will be assembled with one of the availa-
ble DNA assembly methods. Since most methods utilize 
either restriction digestion or homologous recombination, 
the map of the DNA molecule that encodes the biosystem 
needs to be laid out nucleotide by nucleotide to ensure ac-
curate assembly. Considering the large number of base pairs, 
this step is usually done in a CAD environment. The early 
though popular DNA design tools such as Vector NTITM [36] 
handle the design on a continuous DNA sequence, which is 
competent for sequence analysis and simple cloning but 
becomes inefficient when designing a large number of con-
structs with standardized parts. New generation of DNA 
CAD tools suit the need of synthetic biology and adopt a 
modular design environment. j5 is a web-based tool that 
takes standard DNA part sequence files as input and designs 
the constructs based on user selected or software recom-
mended assembly strategy [37]. j5 has automated the design 
process and is capable of processing libraries of DNA con-
structs in a high throughput manner. RAVEN is a newly 
reported tool that not only automates the design process, but 
also optimizes the assembly plan by self-learning algorithm 
with experimental results [38].  
2  Build 
2.1  Assembly methods 
DNA assembly methods play a fundamental role in biofab-
rication. Recently, a number of DNA assembly methods 
have been developed with improved modularity, efficiency, 
and fidelity that fulfill the increasing demand in synthetic 
biology. Since most of the methods have been recapitulated 
in previous reviews [2,39], only the ones that can be poten-
tially applied in the biofabrication process are briefly dis-
cussed here (Figure 2). 
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Figure 2 (color online)  Summary of key DNA assembly methods. A, DNA fragments are treated by restriction endonucleases to generate compatible ends 
and then ligated by ligase to create circular constructs. B, DNA fragments with overlapping regions are treated by exonuclease to generate single-stranded 
complementary overhangs and joined by DNA polymerase and ligase. C, Host organisms are directly transformed by DNA fragments with overlapping re-
gions. The constructs are assembled by homologous recombination in vivo. D, Two neighboring fragments are annealed to a bridging oligo and then ligated 
by DNA ligase.  
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The BioBrickTM standard utilizes restriction endonucle-
ase isocaudamers Xba I (TCTAGA) and Spe I (ACTAGT) 
to generate two compatible sticky ends (CTAG) on the re-
ceiver and donor plasmids respectively for ligation [40]. 
The newly generated scar sequence (ACTAGA) between 
the two DNA parts cannot be cut in subsequent digestions 
by neither enzyme, while new EcoR I and Xba I sites are 
introduced on the other end of the inserted fragment, which 
allows iterative digestion and ligation. To solve the frame 
shift problem of the original BioBrickTM standard in protein 
fusion applications, modified standards were proposed 
[4143]. The Golden Gate method [44] relies on Type IIs 
restriction enzymes like Bsa I, which is able to cleave DNA 
outside of their recognition site and produce an overhang of 
four arbitrary nucleotides. Once ligated, the resultant frag-
ment cannot be cut anymore unless the recognition site was 
purposely retained. The protocol combines digestion and 
ligation in one pot, which can greatly increase the efficiency 
by driving this irreversible reaction towards completion.  
The application of restriction enzyme based methods in 
constructing large constructs is relatively limited since the 
occurrence of designated restriction sites increases with the 
size of fragments, which need to be removed by either 
site-directed mutagenesis or de novo synthesis. Sequence 
homology based methods do not need restriction digestion 
to generate sticky ends but use longer arbitrary overlapping 
regions between parts. Gibson isothermal assembly gener-
ates single-stranded complementary overhangs by digestion 
on the 5′ ends with T5 exonuclease [45]. The annealed ends 
are then jointed by Phusion DNA polymerase and Taq DNA 
ligase. All reactions happen in the same buffer at 50°C. S. 
cerevisiae has a highly efficient natural homologous recom-
bination machinery. With this machinery, Gibson and 
coworkers [46] have reconstructed the Mycoplasma genita-
lium genome by assembling 25 DNA fragments. Shao and 
co-workers [23] have also developed DNA assembler, a 
robust method to assemble pathways in yeast. Similarly, 
homologous recombination based assembly was performed 
in other organisms such as Bacillus subtilis [47,48], plants 
[49,50] and engineered E. coli [51,52].  
In 2000, Pachuk and co-workers [53] developed a meth-
od named chain reaction cloning (CRC) to assemble DNA 
fragments facilitated by designed single strand bridging 
oligos which are complementary to two ends of neighboring 
DNA parts. Researchers at Amyris (San Francisco, USA) 
systematically optimized this method and developed ligase 
cycling reaction (LCR) to reliably assemble thousands of 
constructs [54].  
2.2  Assembly schemes 
Robust, broadly accessible strategies for constructing mul-
tigene pathways are highly desired in synthetic biology. An 
iterative integration scheme for expressing multigene path-
ways was proposed by Wingler and Cornish [55]. Two dis-
tinct markers were used alternately to provide selective 
pressure for the incorporation of each fragment by homolo-
gous recombination. This sequential integration strategy 
improved assembly fidelity, however, at a cost of time. By 
contrast, one-step assembly allows faster construction of 
multiple fragments into one construct, although it is not 
easy to achieve the same level of fidelity and efficiency. 
Many efforts have been made to tackle this issue. 
Non-homologous end joining (NHEJ) of linear fragments is 
one of the commonly seen problems in homologous recom-
bination based methods. To suppress the false positive 
clones, a counter-selective marker can be introduced at the 
cloning site on the vector [56]. Therefore, the host is forced 
to replace the adverse gene with the designated inserts. An-
other strategy is to separate selection marker and episome, 
the two essential elements on the vector to reduce the prob-
ability of false positives since at least two NHEJs are re-
quired to incorporate both elements into a self-replicable 
circular molecule [57]. 95% fidelity was achieved when 
assembling nine fragments.  
Unique overlapping linker regions are responsible for 
joining and addressing DNA fragments in many assembly 
methods. The linker sequences can be optimized to achieve 
better assembly robustness. Liang and co-workers [58] ex-
perimentally optimized the 4-bp linkers in Golden Gate 
method for synthesizing transcription activator-like effec-
tors nucleases (TALENs). TALENs are proteins that cleave 
target DNA sequences with tailored series of central repeat 
domains (CRDs) and are widely used in genome editing. 
Large-scale application of TALENs is hindered by the 
time-consuming synthesis protocol. The optimized linkers 
made it possible to assemble 13 fragments or DNA se-
quences coding for up to 31 CRDs in one step with 96% 
fidelity. Hence, the assembly scheme is simplified which 
enables the synthesis process readily automatable. Most 
homology based methods like Gibson assembly allow as-
sembly of multiple genetic parts in one step. Nonetheless, 
they often suffer from unspecific annealing when dealing 
with highly repetitive sequences. Instead of the endogenous 
sequences, synthetic linkers which are optimized in param-
eters like orthogonality, GC content, melting temperature, 
and secondary structures can be used to improve the effi-
ciency and fidelity [5961]. Moreover, the use of 
pre-defined linker sets makes DNA construct design more 
modular. With synthetic linkers, new schemes based on 
Gibson method were developed to efficiently assemble 
large mammalian genetic circuits [59,60].  
2.3  De novo synthesis and assembly automation  
Most DNA parts used in synthetic biology today are copies 
of existing sequences in nature. To make the biosystems 
fully reprogrammable, the parts need to be synthesized de 
novo. Parts can also be customized by restriction site re-
moval, linker addition, as well as codon optimization to 
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make the assembly and expression easier. Typical de novo 
synthesized DNA molecules are assemblies of chemically 
synthesized oligonucleotides [62]. Owing to the invention 
of microarray based DNA synthesis, large amount of oligos 
can be densely “printed” on a DNA chip, which greatly in-
creased the throughput and lowered the cost. The newly 
developed assembly methods have also made it more relia-
ble to build from oligos to a few thousand base pairs long 
molecules. Thus we have witnessed great breakthroughs in 
the past few years. In 2008, a 583 kb M. genitalium has 
been synthesized by the J. Craig Venter Institute [63]. In 
2010, a M. genitalium cell with the chemically synthesized 
genome was created, of which the phenotype matched the in 
silico design [64]. On the eukaryote side, a functional de-
signer S. cerevisiae chromosome III with multi-loci modifi-
cations was successfully synthesized [65]. Beside their sig-
nificance in synthetic biology, these pieces of ground- 
breaking work have also provided more evidences to the 
long lasting question: can life be created?  
No matter whether DNA parts were de novo synthesized 
or amplified from existing templates, DNA assembly still 
remains a critical and labor-intensive step in the build pro-
cess. The considerable labor cost, high error rate, and insuf-
ficient throughput in manual assembly operations limit the 
number of designs that can be prototyped. Ideally, research-
ers should focus more on creative designing work instead of 
mechanical assembly experiments. With more and more 
robust DNA assembly methods, automating DNA assembly 
became possible. In the previously discussed high- 
throughput TALEN synthesis work [58], a computational 
tool was programmed to convert TALEN binding sequences 
to scripts for liquid handling stations. The RVD parts could 
be automatically pipetted to designated wells for TALEN 
synthesis. Through automation, the labor cost was greatly 
reduced and pipetting mistakes were avoided. By transfer-
ring the know-hows from industrial automation, the state- 
of-art laboratory automation systems can conduct most of 
the molecular biology operations. Therefore, the depth of 
automation in DNA assembly can be further extended to 
eliminate human interventions.  
3  Test 
3.1  Genotyping 
The essence of synthetic biology is to build biosystems as 
designed, which requires exact control in each prototyping 
step. As quality control, DNA constructs are usually veri-
fied after assembly. Likewise, the mutations of extensively 
edited genome with desired traits need to be traced in order 
to precisely elucidate the phenotype. Thus genotyping tool 
is an important node in the biofabrication line.  
DNA sequencing is the ultimate tool for construct verifi-
cation because it reveals the assembly fidelity to single nu-
cleotide resolution. However, cost and read length of Sanger 
sequencing, the most commonly used method for small 
DNA constructs, are obvious barriers for scaling up. Hence 
restriction digestion followed by gel electrophoresis is usu-
ally adopted on the bench side. To fulfill the requirement of 
high-throughput biofabrication, this process has been auto-
mated [66]. A computational tool was exploited to select 
restriction enzyme combinations to optimize the digestion 
pattern according to the designs of the constructs. Liquid 
handling stations followed the digestion design to pick en-
zymes from a stock library. The digestion patterns were 
analyzed with a high-throughput capillary electrophoresis 
system, and then compared with the prediction. Next-  
generation sequencing has revolutionized genotyping, 
which makes large-scale sequencing possible [67]. On the 
other hand, the cost has been greatly lowered due to the 
parallel sequencing capability. The smallest Illumina® se-
quencer can generate 25 million reads on a single run, 
which provides enough coverage for an entire microbial 
genome or hundreds of plasmids. If samples are individual-
ly barcoded, the reads can be readily aligned to the corre-
sponding reference genome or plasmid design. Since the 
fixed cost on each sequencing run contributes most to the 
total cost, maximizing the number of samples will bring the 
per sample cost down to an acceptable level. When the bio-
fabrication process scales up, next-generation sequencing 
may become an ideal method to verify DNA constructs.  
3.2  Phenotyping 
High throughput analysis of intracellular/extracellular me-
tabolites is an essential step in prototyping biosystems. The 
widely used conventional methods for metabolite analysis 
include nuclear magnetic resonance (NMR), gas chroma-
tography-mass spectrometry (GC-MS), liquid chromatog-
raphy-mass spectrometry (LC-MS), capillary electrophore-
sis-mass spectrometry (CE-MS), and matrix-assisted laser 
desorption ionization-mass spectrometry (MALDI-MS). 
NMR is a powerful technique for metabolite profiling and 
allows direct identification and quantification of abundant 
analytes [68], yet the throughput is limited by the compli-
cated sample preparation and instrument operation. GC-MS 
offers efficient separation of non-polar and volatile metabo-
lites with high resolution, reproducibility, and relatively low 
operating cost [69]. Derivatization step is required for de-
tection of polar and non-volatile metabolites [70]. Latest 
GC-MS systems feature automatic sample preparation, 
derivatization and injection, which reduced analytical time 
and human intervention. LC-MS, on the other hand, allows 
analysis of a wide range of metabolites without prior deri-
vatization, especially when coupled with the electrospray 
ionization (ESI) method. Some recent advances significant-
ly improved the resolution power and peak capacity [71]. 
For identification of unknown metabolites, tandem mass 
spectrometry (MS/MS) has been applied in which two or 
more mass analyzers are coupled by collision-induced ioni-
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zation chambers (e.g., Q-TOF). CE-MS is considered one of 
the most versatile analytical techniques in proteomics and 
metabolomics [72]. CE separates analytes based on their 
charge and size, which is capable of analyzing a diverse 
range of chemical compounds, charged or polar molecules 
with minimal sample preparation. Therefore, it has good 
potential for high throughput metabolite analysis and even 
single cell metabolomics and subcellular structure study 
[73]. The resolution of CE, in many cases, is higher than 
LC-MS because the capillary in CE usually provides better 
plug flow of analytes hence narrower peaks than that of the 
chromatography column in LC [74]. Compared to other 
MS-based analytical methods, MALDI-MS has higher sen-
sitivity and smaller sample volume. Moreover, MALDI-MS 
is a high throughput technique due to its ability to analyze a 
large number of metabolites in one shot with direct ioniza-
tion mechanism [75]. The choice of matrix is critical in 
MALDI-MS analysis. Other than conventional matrices like 
DHB (2,5-dihydroxybenzoic acid) and CHCA (alpha-  
cyano-4-hydroxy-cinnamic acid), 9-aminoacridine (9-AA) 
has been reported as a better matrix in quantitative detection 
of metabolites [76]. Based on 9-AA matrix, a MALDI-MS- 
based approach was reported by Yukihira and co-workers 
which enables high sensitivity and high throughput metabo-
lite analysis for intracellular metabolic dynamics [75]. This 
high throughput method potentially enables large-scale 
analysis that deals with tens of thousands of samples and 
even real-time monitoring of intracellular metabolism. The 
recent MS advances even enable the analysis of a single 
yeast cell [77,78]. Cells were first deposited on hydrophilic 
reservoirs in a microarray chip and ionized by laser irradia-
tion. The concentrations of central intermediates of energy 
metabolism were measured by MALDI-MS.  
4  Conclusion 
In its relatively short history, synthetic biology has made 
great progress in accelerating the design-build-test cycle. A 
number of advanced tools in each process of the cycle have 
sketched a preliminary blueprint for future automated bio-
fabrication. Some steps have been already automated for a 
few specific types of biosystems. These steps include but 
are not limited to DNA assembly design and construct veri-
fication. Steps like pathway design, genetic circuit design, 
DNA assembly, and metabolite analysis are also partially 
automated. Given the short time span all these advances 
happened, we can be confident to foresee that a “proto-
type-on-demand” capability will become available in the 
near future.  
The future for high throughput synthetic biology is 
promising yet challenging. In the design process, genetic 
circuit can be designed and simulated in a CAD environ-
ment, but the simulation fidelity will drop with increasing 
circuit complexity due to the incomplete characterization 
data of parts. The synthetic routes recommended by retro-
biosynthesis algorithms are still selected in an artisanal ap-
proach. Once a route is selected, a set of enzymes that is 
most likely to catalyze the reactions are usually handpicked. 
Although there are tools available to assist the selection 
based on structure comparison against the databases, the 
total possibilities are still vast [29]. The assembly methods 
for building DNA molecules need higher efficiency and 
fidelity for robust automation. The modularity needs to be 
further improved for easier design. Most analytical methods 
for phenotyping lack multiplexing capacity to achieve de-
sired throughput. Lastly, integrating existing technologies in 
a fully automated biofabrication facility still requires exten-
sive engineering effort to follow up.  
Cheerfully, significant resources are being invested from 
both governments and industries around the world that 
should take synthetic biology to a new era. Among the pio-
neers are the Defense Advanced Research Projects Agency 
(DARPA) in the USA and Biotechnology and Biological 
Sciences Research Council (BBSRC) in UK. With an in-
creasing number of researchers attempting to develop high 
throughput synthetic biology tools, we believe that estab-
lishing industrialized “biological foundries” is just a matter 
of time.  
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